Increasing prevalence of chronic diseases in North America is expected to bolster the market growth
North America holds dominant position in the global electrical stimulation devices market, owing to high prevalence of chronic diseases. According to National Center for Biotechnology Information (NCBI), March 2018, an estimated 45%, or around 33 million Americans were diagnosed by at least one chronic disease.
Moreover, rise in geriatric population, who are highly susceptible to pain, is expected to bolster the market growth over the forecast period.
According to American Psychological Association, 2014 report, around 40 million people over the age 65 years account for 14% of total population and around 60% to 75% of people over age 65 years are diagnosed with persistent pain.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients